These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6494240)
1. Therapist compliance or phase IV necessities. Linden M Pharmacopsychiatry; 1984 Sep; 17(5):139. PubMed ID: 6494240 [No Abstract] [Full Text] [Related]
2. Some problems in the conduct of psychotropic drug trials (a review). Doongaji DR; Parikh MD J Postgrad Med; 1983 Apr; 29(2):67-74. PubMed ID: 6631765 [No Abstract] [Full Text] [Related]
3. [Clinical trials of drugs. Special features of clinical studies of analgesics and psychotropic drugs]. Hennemann A Med Monatsschr Pharm; 2003 Jul; 26(7):224-6. PubMed ID: 12879619 [No Abstract] [Full Text] [Related]
4. [Clinical evaluation of psychotropic drugs]. Nieto D Bol Estud Med Biol; 1974; Suppl 1():309-17. PubMed ID: 4619018 [No Abstract] [Full Text] [Related]
5. Psychopharmacology. The medication merry-go-round. Brown K Science; 2003 Mar; 299(5613):1646-9. PubMed ID: 12637713 [No Abstract] [Full Text] [Related]
6. [Guidelines for carrying out application studies in psychopharmacotherapy. "Phase IV Research" Study Group of the Society of Neuropsychopharmacology and Pharmacopsychiatry]. Linden M; Baier D; Beitinger H; Kohnen R; Osterheider M; Philipp M; Reimitz PE; Schaaf B; Weber HJ Nervenarzt; 1994 Sep; 65(9):638-44. PubMed ID: 7991013 [No Abstract] [Full Text] [Related]
7. Placebo effect of psychotropic drugs on patients and staff. Galiana M Rev Neuropsychiatr Infant; 1977; 25(5-6):329-33. PubMed ID: 331432 [No Abstract] [Full Text] [Related]
9. Problems of drug treatment of mental disorders. Vartanian FE Adv Biochem Psychopharmacol; 1980; 24():603-7. PubMed ID: 6996446 [No Abstract] [Full Text] [Related]
10. Disparities in drug development: the Japanese paradox. Kanba S J Psychiatry Neurosci; 1999 Jan; 24(1):13-4. PubMed ID: 9987203 [No Abstract] [Full Text] [Related]
12. [Use of sultopride in child and adolescent psychiatry]. Dugas M; Le Heuzey MF Neuropsychiatr Enfance Adolesc; 1984; 32(10-11):557-62. PubMed ID: 6395036 [No Abstract] [Full Text] [Related]
13. Psychologist prescribing: the issues in Maryland. Prescott WG Md Med; 2002; 3(4):26-8. PubMed ID: 12481744 [No Abstract] [Full Text] [Related]
14. Psychiatric drug trials and placebo. Koponen H; Lepola U Nord J Psychiatry; 2005; 59(4):233-7. PubMed ID: 16195126 [TBL] [Abstract][Full Text] [Related]
15. Guidelines for the evaluation of drugs in the elderly neuropsychiatric patients (demented and non-demented). Pharmacopsychiatria; 1981 Sep; 14(5):190-9. PubMed ID: 7291302 [No Abstract] [Full Text] [Related]
16. [Ethical and legal problems in first clinical trials of psychotropic drugs (author's transl)]. Helmchen H Arzneimittelforschung; 1978; 28(8):1253-6. PubMed ID: 380572 [TBL] [Abstract][Full Text] [Related]
17. [Psychotropic pharmacotherapy, treatment compliance and prescription observance]. Grasset F; Bonvin E; Pomini V Rev Med Suisse Romande; 2000 Feb; 120(2):137-43. PubMed ID: 10748700 [No Abstract] [Full Text] [Related]
18. Medicine. What are the right targets for psychopharmacology? Hyman SE; Fenton WS Science; 2003 Jan; 299(5605):350-1. PubMed ID: 12532001 [No Abstract] [Full Text] [Related]
19. National and international guidelines for the conduct of clinical trials of psychotropic drugs. Müller-Oerlinghausen B Psychopharmacol Ser; 1990; 8():167-74. PubMed ID: 2377597 [No Abstract] [Full Text] [Related]
20. Clinical factors that may confound the assessment of drug efficacy. Csernansky JG; Newcomer JW; Miller LS; Faustman WO Psychopharmacol Bull; 1991; 27(3):231-5. PubMed ID: 1775593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]